# A Study of LY2784544 in Healthy Male Subjects

> **NCT01577355** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 8 (estimated)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **RADIATION:** Drug

## Key facts

- **NCT ID:** NCT01577355
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2012-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01577355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01577355, "A Study of LY2784544 in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01577355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*